Correction to Lancet Oncol 2018; 19: 510-20

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2018 Apr.

. 2018 Apr;19(4):e184.

doi: 10.1016/S1470-2045(18)30209-2.

No abstract available

Erratum for

Adjuvant vemurafenib in resected, BRAF^V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Maio M, Lewis K, Demidov L, Mandalà M, Bondarenko I, Ascierto PA, Herbert C, Mackiewicz A, Rutkowski P, Guminski A, Goodman GR, Simmons B, Ye C, Yan Y, Schadendorf D; BRIM8 Investigators. Maio M, et al. Lancet Oncol. 2018 Apr;19(4):510-520. doi: 10.1016/S1470-2045(18)30106-2. Epub 2018 Feb 21. Lancet Oncol. 2018. PMID: 29477665 Clinical Trial.